Effect of oral coadministration of artesunate with ferrous sulfate on rat liver mitochondrial membrane permeability transition

References

• Agarwal, K. N. (2001). Iron and the brain: neurotransmitter receptors and magnetic resonance spectroscopy. Br J Nutr 85:S147–S150
   PubMed Web of Science ®Google Scholar
• Anyasor, G. N., Ajayi, E., Saliu, J. A., Ajagbonna, O., Olorunsogo, O. O. (2009). Artesunate opens mitochondrial membrane permeability transition pore. Ann Trop Med Public Health 2:37–41.
   Google Scholar
• Beard, J. L., Wiesinger, J. A., Connor, J. R. (2003). Pre- and postweaning iron deficiency alters myelination in Sprague-Dawley rats. Dev Neurosci 25:308–315.
   PubMed Web of Science ®Google Scholar
• Crompton, M. (1999). The mitochondrial permeability transition pore and its role in cell death. Biochem J 341:233–249.
   PubMed Web of Science ®Google Scholar
• Eckstein-Ludwig, U., Web, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., et al. (2003). Artemisinin target the SERCA of P. falciparum. Nature 424:957–961.
   PubMed Web of Science ®Google Scholar
• Efferth, T., Olbrich, A., Bauer, R. (2002). mRNA expression profiles for the response of human tumor lines to the antimalaria drugs artesunate, arteether, and artemether. Biochem Pharmacol 64:617–623.
   PubMed Web of Science ®Google Scholar
• Efferth, T., Sauerbrey, A., Olbrich, A., Gebhart, E., Rauch, P., Weber, H., et al. (2003). Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 64:382–394.
   PubMed Web of Science ®Google Scholar
• Halliwell, B., Gutteridge, J. M. C. (1984). Oxygen toxicity, oxygen radicals, transition metals, and disease. Biochem J 219:1–14.
   PubMed Web of Science ®Google Scholar
• Hawkins, R. A., Sangster, K., Arends, M. J. (1998). Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 185:61–70.
   PubMed Web of Science ®Google Scholar
• Johnson, D., Lardy, H. (1967). Isolation of liver or kidney mitochondria. Meth Enzymol 10:94–96.
   Google Scholar
• King, E. J., King, P. R. N. (1954). Estimation of plasma phosphatase by determination of hydrolyzed phenol with amino-antipyrene. J Chem Path 7:322–326.
   Web of Science ®Google Scholar
• Kumar, N., Zheng, H. (1990). Stage-specific gametocytocidal effect in vitro of the antimalaria drug quinghaosu on P. falciparum. Parasitol Res 76:214–218
   PubMed Web of Science ®Google Scholar
• Kuvibidila, S. R., Kitchens, D., Baliga, B. S. (1999). In vivo and in vitro iron deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells. J Cell Biochem 74:468–478.
   PubMed Web of Science ®Google Scholar
• Lai, H., Singh, N. P. (1995). Selective cancer cell cytotoxity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 91:41–46.
   PubMed Web of Science ®Google Scholar
• Lai, H., Singh, N.P. (2001). Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer. Life Sci 70:49–56.
   PubMed Web of Science ®Google Scholar
• Lapidus, R. G., Sokolove, P. M. (1993). Spermine inhinbition of the permeability transition of isolated rat liver mitochondria: an investigation mechanism. Arch Biochem Biophys 306:246–253.
   PubMed Web of Science ®Google Scholar
• Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951). Protein measurement with Folin-Phenol reagent. J Biol Chem 193:265–275.
   PubMed Web of Science ®Google Scholar
• Meshnick, S. R. (2002). Artemisinin: mechanisms of action, resistance, and toxicity. Int J Parasitol 32:1655–1660.
   PubMed Web of Science ®Google Scholar
• Meshnick, S. R., Taylor, T. E., Kamchonwongpaisan, S. (1996). Artemisinin and the antimalaria endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev 60:301–315.
   PubMedGoogle Scholar
• Modica-Napolitano, J. S., Singh, K. K. (2002). Mitochondria as targets for detection and treatment of cancer. Exp Rev Mol Med 4:1–19.
   PubMedGoogle Scholar
• Murray, R. K., Granner, D. K., Mayes, P. A., Rodwell, V. W. (2003). Harper’s illustrated biochemistry, 26th ed. New York: McGraw-Hill.
   Google Scholar
• Ngokere, A. A., Ngokere, T. C., Ikwudinma, A. P. (2004). Acute study of histomorphological and biochemical changes caused by artesunate in visceral organs of the rabbit. J Exp Clin Anat 3:11–16.
   Google Scholar
• Olliaro, P. L., Haynes, R. K., Meunier, B., Yuthavong, Y. (2001). Possible mode of action of artemisinin-type compounds. Trends Parasitol 17:122–126.
   PubMed Web of Science ®Google Scholar
• Olorunsogo, O.O., Bababunmi, E.A. (1980). Inhibition of succinate-linked reduction of pyridine nucleotide in rat liver mitochondria ‘in vivo’ by N-Cphosphonomethyl glycine. Toxicol Lett 7(2):149–152.
   PubMed Web of Science ®Google Scholar
• Ortiz, E., Pasquini, J. M., Thompson, K., Felt, B., Butkus, G., Beard, J., et al. (2004). Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 77:681–689.
   PubMed Web of Science ®Google Scholar
• Posner, G. (1998). Antmalarial peroxides in the qinghaosu (artemisinin) and yinghaosu families. Exp Opin Ther Patents 8:1487–1493.
   Web of Science ®Google Scholar
• Reitman, S., Frank, S. (1957). Transaminases. Am J Clin Path 28:56.
   PubMed Web of Science ®Google Scholar
• Spear, A. T., Sherman, A. R. (1992). Iron deficiency alters DMBA-induced tumour burden and natural killer cell cytotoxicity rats. J Nutr 122:46–55.
   PubMed Web of Science ®Google Scholar
• Wardlaw, G. N. (1999). Perspectives in nutrition, 4th ed. (pp 472–502). Boston: McGraw- Hill.
   Google Scholar
• Widmann, F. K. (1980). Clinical interpretation of laboratory tests, 9th ed. (pp 293–295). Washington, DC: American Association of Publishers.
   Google Scholar
• Woodrow, C.J., Haynes, R.K., Krishna, S. (2005). Artemisinins. Postgrad Met J 81:71–78.
   Google Scholar